Docusign (NASDAQ:DOCU) Price Target Increased to $86.00 by Analysts at JMP Securities
Docusign (NASDAQ:DOCU) had its price target hoisted by JMP Securities to $86.00 in a report issued on Friday morning, The Fly reports. They currently have an outperform rating on the stock.
Several other research analysts have also recently issued reports on the company. KeyCorp set a $65.00 price target on Docusign and gave the stock a buy rating in a research note on Friday, September 6th. JPMorgan Chase & Co. lifted their price objective on shares of Docusign from $88.00 to $90.00 and gave the company an overweight rating in a research note on Friday, September 6th. Royal Bank of Canada upped their price objective on shares of Docusign from $80.00 to $93.00 and gave the stock an outperform rating in a report on Monday, December 2nd. Morgan Stanley increased their target price on shares of Docusign from $61.00 to $67.00 and gave the company an overweight rating in a research report on Friday, September 6th. Finally, Citigroup raised their target price on shares of Docusign from $60.00 to $72.00 and gave the company a buy rating in a research note on Friday, September 6th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The company has a consensus rating of Buy and a consensus target price of $74.75.
Shares of NASDAQ DOCU traded up $6.07 during midday trading on Friday, hitting $75.57. 9,973,185 shares of the company’s stock were exchanged, compared to its average volume of 2,561,481. Docusign has a twelve month low of $36.25 and a twelve month high of $75.85. The firm has a market cap of $13.30 billion, a P/E ratio of -26.06 and a beta of 1.46. The stock’s 50 day moving average price is $67.85 and its 200-day moving average price is $57.15. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.64 and a quick ratio of 1.64.
In other Docusign news, COO Scott V. Olrich sold 2,000 shares of the company’s stock in a transaction dated Wednesday, September 11th. The shares were sold at an average price of $59.50, for a total value of $119,000.00. Also, COO Scott V. Olrich sold 4,000 shares of the company’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $58.98, for a total transaction of $235,920.00. Insiders have sold 44,698 shares of company stock valued at $2,849,129 in the last ninety days. Company insiders own 13.60% of the company’s stock.
Several institutional investors and hedge funds have recently made changes to their positions in the company. North Star Investment Management Corp. acquired a new stake in Docusign during the third quarter valued at approximately $25,000. Hartford Financial Management Inc. bought a new stake in shares of Docusign during the 3rd quarter worth $31,000. Whittier Trust Co. grew its holdings in shares of Docusign by 229.4% in the 3rd quarter. Whittier Trust Co. now owns 560 shares of the company’s stock worth $35,000 after acquiring an additional 390 shares during the last quarter. Wealthcare Advisory Partners LLC acquired a new position in shares of Docusign in the 2nd quarter worth $36,000. Finally, Migdal Insurance & Financial Holdings Ltd. raised its position in shares of Docusign by 261.0% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 769 shares of the company’s stock worth $38,000 after purchasing an additional 556 shares during the period. 81.67% of the stock is currently owned by institutional investors.
DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.
Further Reading: Cash Asset Ratio
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.